Found: 38
Select item for more details and to access through your institution.
Non-Obese MAFLD Is Associated with Colorectal Adenoma in Health Check Examinees: A Multicenter Retrospective Study.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 11, p. 5462, doi. 10.3390/ijms22115462
- By:
- Publication type:
- Article
Impact of Decorin on the Physical Function and Prognosis of Patients with Hepatocellular Carcinoma.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 4, p. 936, doi. 10.3390/jcm9040936
- By:
- Publication type:
- Article
Association between Activity and Brain-Derived Neurotrophic Factor in Patients with Non-Alcoholic Fatty Liver Disease: A Data-Mining Analysis.
- Published in:
- Life (2075-1729), 2021, v. 11, n. 8, p. 799, doi. 10.3390/life11080799
- By:
- Publication type:
- Article
Impact of metabolic dysfunction‐associated fatty liver disease on the incidence of Helicobacter pylori‐negative gastric cancer.
- Published in:
- Hepatology Research, 2024, v. 54, n. 6, p. 540, doi. 10.1111/hepr.14010
- By:
- Publication type:
- Article
Metabolic management after sustained virologic response in elderly patients with hepatitis C virus: A multicenter study.
- Published in:
- Hepatology Research, 2024, v. 54, n. 4, p. 326, doi. 10.1111/hepr.13993
- By:
- Publication type:
- Article
Impact of non‐obese metabolic dysfunction‐associated fatty liver disease on risk factors for the recurrence of esophageal squamous cell carcinoma treated with endoscopic submucosal dissection: A multicenter study.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 201, doi. 10.1111/hepr.13973
- By:
- Publication type:
- Article
The beneficial impact of metabolic dysfunction‐associated fatty liver disease on lenvatinib treatment in patients with non‐viral hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2023, v. 53, n. 2, p. 104, doi. 10.1111/hepr.13843
- By:
- Publication type:
- Article
Lean/normal‐weight metabolic dysfunction‐associated fatty liver disease is a risk factor for reflux esophagitis.
- Published in:
- Hepatology Research, 2022, v. 52, n. 8, p. 699, doi. 10.1111/hepr.13795
- By:
- Publication type:
- Article
Metabolic dysfunction‐associated fatty liver disease directly related to liver fibrosis independent of insulin resistance, hyperlipidemia, and alcohol intake in morbidly obese patients.
- Published in:
- Hepatology Research, 2022, v. 52, n. 10, p. 841, doi. 10.1111/hepr.13808
- By:
- Publication type:
- Article
Association between the albumin–bilirubin (ALBI) score and severity of portopulmonary hypertension (PoPH): A data‐mining analysis.
- Published in:
- Hepatology Research, 2021, v. 51, n. 12, p. 1207, doi. 10.1111/hepr.13714
- By:
- Publication type:
- Article
MAFLD: Renovation of clinical practice and disease awareness of fatty liver.
- Published in:
- Hepatology Research, 2022, v. 52, n. 5, p. 422, doi. 10.1111/hepr.13706
- By:
- Publication type:
- Article
Atherosclerotic cardiovascular disease in non‐metabolic nonalcoholic fatty liver disease.
- Published in:
- Hepatology Research, 2022, v. 52, n. 3, p. 317, doi. 10.1111/hepr.13738
- By:
- Publication type:
- Article
MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach.
- Published in:
- Hepatology Research, 2021, v. 51, n. 11, p. 1115, doi. 10.1111/hepr.13685
- By:
- Publication type:
- Article
Effects of a low‐intensity resistance exercise program on serum miR‐630, miR‐5703, and Fractalkine/CX3CL1 expressions in subjects with No exercise habits: A preliminary study.
- Published in:
- Hepatology Research, 2021, v. 51, n. 7, p. 823, doi. 10.1111/hepr.13670
- By:
- Publication type:
- Article
Profiles of advanced hepatic fibrosis evaluated by FIB‐4 index and shear wave elastography in health checkup examinees.
- Published in:
- Hepatology Research, 2020, v. 50, n. 2, p. 199, doi. 10.1111/hepr.13436
- By:
- Publication type:
- Article
Clinical utility of the Liver Frailty Index for predicting muscle atrophy in chronic liver disease patients with hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2020, v. 50, n. 3, p. 330, doi. 10.1111/hepr.13453
- By:
- Publication type:
- Article
Slow walking speed overlapped with low handgrip strength in chronic liver disease patients with hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2019, v. 49, n. 12, p. 1427, doi. 10.1111/hepr.13405
- By:
- Publication type:
- Article
Spontaneous regression of hepatocellular carcinoma with reduction in angiogenesis‐related cytokines after treatment with sodium‐glucose cotransporter 2 inhibitor in a cirrhotic patient with diabetes mellitus.
- Published in:
- Hepatology Research, 2019, v. 49, n. 4, p. 479, doi. 10.1111/hepr.13247
- By:
- Publication type:
- Article
Effects of In-Hospital Exercise on Frailty in Patients with Hepatocellular Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 2, p. 194, doi. 10.3390/cancers13020194
- By:
- Publication type:
- Article
Weekends-Off Lenvatinib for Unresectable Hepatocellular Carcinoma Improves Therapeutic Response and Tolerability Toward Adverse Events.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 1010, doi. 10.3390/cancers12041010
- By:
- Publication type:
- Article
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD.
- Published in:
- Liver International, 2020, v. 40, n. 12, p. 3018, doi. 10.1111/liv.14675
- By:
- Publication type:
- Article
Similar respiratory function including chronic obstructive pulmonary disease between non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease.
- Published in:
- Clinical & Molecular Hepatology, 2024, v. 30, n. 2, p. 266, doi. 10.3350/cmh.2024.0028
- By:
- Publication type:
- Article
Changing from NAFLD to MASLD: Similar cumulative incidence of reflux esophagitis between NAFLD and MASLD.
- Published in:
- Clinical & Molecular Hepatology, 2024, v. 30, n. 1, p. 121, doi. 10.3350/cmh.2023.0437
- By:
- Publication type:
- Article
Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunc- tion-associated fatty liver disease: Directed acyclic graphs.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 2, p. 269, doi. 10.3350/cmh.2022.0040
- By:
- Publication type:
- Article
MAFLD enhances clinical practice for liver disease in the Asia-Pacific region.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 2, p. 150, doi. 10.3350/cmh.2021.0310
- By:
- Publication type:
- Article
Patient‐reported outcomes in patients with non‐alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire‐non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 3, p. 629, doi. 10.1111/jgh.15172
- By:
- Publication type:
- Article
MAFLD associated with COPD via systemic inflammation independent of aging and smoking in men.
- Published in:
- Diabetology & Metabolic Syndrome, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13098-022-00887-w
- By:
- Publication type:
- Article
Effects of canagliflozin on growth and metabolic reprograming in hepatocellular carcinoma cells: Multi-omics analysis of metabolomics and absolute quantification proteomics (iMPAQT).
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0232283
- By:
- Publication type:
- Article
Effects of isomaltulose on insulin resistance and metabolites in patients with non‑alcoholic fatty liver disease: A metabolomic analysis.
- Published in:
- Molecular Medicine Reports, 2018, v. 18, n. 2, p. 2033, doi. 10.3892/mmr.2018.9223
- By:
- Publication type:
- Article
Effects of In-Hospital Physical Therapy on Activities of Daily Living in Patients with Hepatocellular Carcinoma.
- Published in:
- International Journal of Environmental Research & Public Health, 2020, v. 17, n. 23, p. 9098, doi. 10.3390/ijerph17239098
- By:
- Publication type:
- Article
Resistance exercise in combination with aerobic exercise reduces the incidence of serious events in patients with liver cirrhosis: a meta-analysis of randomized controlled trials.
- Published in:
- Journal of Gastroenterology, 2024, v. 59, n. 3, p. 216, doi. 10.1007/s00535-023-02060-0
- By:
- Publication type:
- Article
Hybrid Training System Improves Insulin Resistance in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Pilot Study.
- Published in:
- Tohoku Journal of Experimental Medicine, 2020, v. 252, n. 1, p. 23, doi. 10.1620/tjem.252.23
- By:
- Publication type:
- Article
Impact of cancer rehabilitation on the prognosis of patients with hepatocellular carcinoma.
- Published in:
- Oncology Letters, 2020, v. 19, n. 3, p. 2355, doi. 10.3892/ol.2020.11345
- By:
- Publication type:
- Article
Hepatic expression of sodium–glucose cotransporter 2 (SGLT2) in patients with chronic liver disease.
- Published in:
- Medical Molecular Morphology, 2022, v. 55, n. 4, p. 304, doi. 10.1007/s00795-022-00334-9
- By:
- Publication type:
- Article
A low‐intensity 10‐min resistance exercise program that ameliorated hepatic fibrosis indices and altered G‐CSF/IP‐10/PDGF‐BB in a patient with nonalcoholic fatty liver disease: A case report.
- Published in:
- JGH Open, 2023, v. 7, n. 3, p. 231, doi. 10.1002/jgh3.12876
- By:
- Publication type:
- Article
Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells.
- Published in:
- JGH Open, 2022, v. 6, n. 4, p. 270, doi. 10.1002/jgh3.12730
- By:
- Publication type:
- Article
Effects of in‐hospital exercise on sarcopenia in hepatoma patients who underwent transcatheter arterial chemoembolization.
- Published in:
- Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 3, p. 580, doi. 10.1111/jgh.14538
- By:
- Publication type:
- Article
The Inter-Organ Crosstalk Reveals an Inevitable Link between MAFLD and Extrahepatic Diseases.
- Published in:
- Nutrients, 2023, v. 15, n. 5, p. 1123, doi. 10.3390/nu15051123
- By:
- Publication type:
- Article